| Authors | W Deenik, H B Beverloo, S C P A M van der Poel-van de Luytgaarde, M M Wattel, J W J van Esser, P J M Valk, J J Cornelissen |
| Journal | Leukemia
(Leukemia)
Vol. 23
Issue 3
Pg. 627-9
(Mar 2009)
ISSN: 1476-5551 [Electronic] England |
| PMID | 18987655
(Publication Type: Case Reports, Letter)
|
| Chemical References |
- NUP214-ABL1 fusion protein, human
- Neoplasm Proteins
- Oncogene Proteins, Fusion
- Pyrimidines
- Thiazoles
- Cytarabine
- Granulocyte Colony-Stimulating Factor
- Vincristine
- Mitoxantrone
- Asparaginase
- Dasatinib
- Prednisone
- Methotrexate
- Daunorubicin
|
| Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Asparaginase
(administration & dosage)
- Combined Modality Therapy
- Cytarabine
(administration & dosage)
- Dasatinib
- Daunorubicin
(administration & dosage)
- Granulocyte Colony-Stimulating Factor
(therapeutic use)
- Humans
- In Situ Hybridization, Fluorescence
- Male
- Methotrexate
(administration & dosage)
- Mitoxantrone
(administration & dosage)
- Neoplasm Proteins
(analysis, antagonists & inhibitors, genetics)
- Neutropenia
(chemically induced, drug therapy)
- Oncogene Proteins, Fusion
(analysis, antagonists & inhibitors, genetics)
- Peripheral Blood Stem Cell Transplantation
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
(complications, diagnosis, drug therapy, enzymology, genetics, surgery)
- Prednisone
(administration & dosage)
- Pyrimidines
(therapeutic use)
- Remission Induction
- Splenic Rupture
(etiology, surgery)
- Thiazoles
(therapeutic use)
- Vincristine
(administration & dosage)
- Young Adult
|
